Published in J Clin Gastroenterol on October 26, 2009
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy. Clinicoecon Outcomes Res (2011) 0.94
Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. J Gen Intern Med (2010) 0.92
Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study. Dig Dis Sci (2012) 0.89
Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics. Dig Dis Sci (2013) 0.81
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey. BMC Infect Dis (2015) 0.79
Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterol (2015) 0.78
Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countries. BMC Health Serv Res (2017) 0.75
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty (2017) 0.75
Treatment of Hepatitis B: A Concise Review. Clin Transl Gastroenterol (2016) 0.75
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N Engl J Med (2015) 6.71
Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol (2006) 2.64
The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol (2008) 2.36
Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol (2008) 2.32
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med (2008) 2.22
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol (2007) 1.86
Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin. J Hepatol (2009) 1.82
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol (2013) 1.65
Genotype-phenotype correlation in Italian children with Wilson's disease. J Hepatol (2008) 1.63
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol (2008) 1.59
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver Int (2012) 1.53
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology (2008) 1.52
Prevention of postoperative recurrence of Crohn's disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol (2012) 1.47
Can Helicobacter pylori eradication regimens be shortened in clinical practice? An open-label, randomized, pilot study of 4 and 7-day triple therapy with rabeprazole, high-dose levofloxacin, and tinidazole. J Clin Gastroenterol (2006) 1.43
Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades. Dig Liver Dis (2010) 1.42
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis (2011) 1.37
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J Antimicrob Chemother (2007) 1.36
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group. Am J Gastroenterol (2005) 1.33
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol (2009) 1.32
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol (2011) 1.29
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol (2011) 1.19
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J (2013) 1.12
Comment to "liver transplantation for patients with alcoholic liver disease: an open question". Dig Liver Dis (2012) 1.12
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol (2002) 1.10
Non-erosive reflux disease is more complex than negative endoscopy only. Am J Gastroenterol (2013) 1.09
Liver transplantation in alcoholic patients. Alcohol Clin Exp Res (2013) 1.08
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci U S A (2013) 1.07
Which anticoagulant drug should be used to treat portal vein thrombosis in patients with chronic liver disease? Clin Gastroenterol Hepatol (2012) 1.07
Comment to "predictors of clinical response of acid suppression in Chinese patients with gastroesophageal reflux disease". Dig Liver Dis (2013) 1.07
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Esophageal acid exposure still plays a major role in patients with NERD. J Gastroenterol (2013) 1.06
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. Clin Oral Investig (2013) 1.06
Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol (2003) 1.05
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr (2004) 1.04
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. J Gastroenterol (2014) 1.04
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol (2004) 1.01
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. Hepatology (2009) 1.00
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet (2012) 1.00
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology (2012) 0.99
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol (2008) 0.99
Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol (2009) 0.99
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia. Dig Liver Dis (2010) 0.99
Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. J Clin Microbiol (2011) 0.98
Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci (2006) 0.97
Thrombocytopenia in liver disease. Curr Opin Hematol (2008) 0.96
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. Int Immunol (2009) 0.96
Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1) deficiency and steroid metabolism. Steroids (2007) 0.94
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int (2013) 0.94
Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis (2011) 0.94
Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointestin Liver Dis (2012) 0.93
Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93
Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) (2013) 0.90
Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome. Nutrition (2006) 0.90
Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis (2013) 0.90
13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol (2005) 0.89
Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period. J Hepatol (2007) 0.89
Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis (2002) 0.89
The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease. J Gastroenterol (2006) 0.88
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment. Expert Opin Drug Metab Toxicol (2013) 0.88
Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clin Gastroenterol Hepatol (2009) 0.87
Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report. Case Rep Infect Dis (2011) 0.86
Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment. Antimicrob Agents Chemother (2013) 0.86
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. Ann N Y Acad Sci (2013) 0.86
Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease. Clin Gastroenterol Hepatol (2010) 0.85
The role of Acid in functional dyspepsia. Am J Gastroenterol (2011) 0.84
[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis]. Recenti Prog Med (2009) 0.84
Treatment of recurrent hepatitis C (genotype 1) with pegylated interferon alfa-2b and ribavirin combination and maintenance therapy. Hepatogastroenterology (2011) 0.84
Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. Blood (2005) 0.84
The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (2009) 0.83
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol (2011) 0.83
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol (2013) 0.83
Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports. AIDS (2002) 0.83
Hepatocellular carcinoma in patients without cirrhosis in Italy. Dig Liver Dis (2012) 0.83
Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis (2011) 0.83
Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest (2013) 0.83
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. World J Gastroenterol (2012) 0.82
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C. J Interferon Cytokine Res (2006) 0.82
Influence of body mass index, cholesterol, triglycerides and steatosis on pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C in patients transplanted for HCV and alcoholic cirrhosis. Hepatogastroenterology (2009) 0.82
Endotherapy for and tailored approaches to treating GERD, and refractory GERD. Ann N Y Acad Sci (2013) 0.82
Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. J Gastrointestin Liver Dis (2011) 0.81
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. World J Gastroenterol (2005) 0.81
Assessment of dietary fiber fermentation: effect of Lactobacillus reuteri and reproducibility of short-chain fatty acid concentrations. Mol Nutr Food Res (2009) 0.81
From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients. Br J Haematol (2008) 0.81
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. Hum Mol Genet (2006) 0.81